This page includes the latest FDA filings for Mobius Therapeutics L L C. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| Registration Number | 3013777332 |
| FEI Number | 3013777332 |
| Name | MOBIUS THERAPEUTICS LLC |
| Owner & Operator | Mobius Therapeutics LLC |
| Contact Address | 1000 Executive Parkway Drive Suite 224 Saint Louis MO 63141 US |
| Official Correspondent |
|
| Registration Status | 1 |
| Initial Importer | Y |
| Registration Expiration | 2020-04-25 |
| Registration Address | 1000 Executive Parkway Drive Suite 224 Saint Louis, MO 63141 US |
Device Company | Device | Date |
|---|---|---|
| Mobius Therapeutics LLC | Prescription Medication | 2025-04-23 |
| Mobius Therapeutics LLC | Prescription Medication | 2024-11-27 |
| Mobius Therapeutics LLC | Prescription Medication | 2022-12-17 |
| Mobius Therapeutics LLC | Prescription Medication | 2021-05-01 |
| Mobius Therapeutics LLC | Prescription Medication | 2020-08-22 |
| Mobius Therapeutics LLC | Prescription Medication | 2018-01-05 |
| Mobius Therapeutics LLC | Mitosol | 2012-02-08 |
| NCAGE Code | 5B1B9 | MOBIUS THERAPEUTICS, LLC |
| CAGE Code | 5B1B9 | MOBIUS THERAPEUTICS, LLC |
| S.A.M. Registration | 5B1B9 [805642118] | MOBIUS THERAPEUTICS, LLC |
| SEC | 0001407296 | Mobius Therapeutics LLC of DELAWARE |